Get started
Penumbra, Inc.Penumbra, Inc.Penumbra, Inc.

Penumbra, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

PEN chart


Full chart

PEN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.10 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
275.36
Basic EPS (TTM)
0.90 USD
Net income (FY)
‪90.95 M‬ USD
Revenue (FY)
‪1.06 B‬ USD
Shares float
‪37.06 M‬
Beta (1Y)
0.75

Employees


Employees (FY)
‪4.2 K‬
Change (1Y)
+300 +7.69%
Revenue / Employee (1Y)
‪252.03 K‬ USD
Net income / Employee (1Y)
‪21.66 K‬ USD

About Penumbra, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Adam Elsesser
Website
penumbrainc.com
Headquarters
Alameda
Founded
2004
FIGI
BBG001BP92V1
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

PEN news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PEN is 240.55 USD — it has increased by 0.88% in the past 24 hours. Watch Penumbra, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Penumbra, Inc. stocks are traded under the ticker PEN.
PEN stock has risen by 0.60% compared to the previous week, the month change is a 14.81% rise, over the last year Penumbra, Inc. has showed a 3.09% increase.
We've gathered analysts' opinions on Penumbra, Inc. future price: according to them, PEN price has a max estimate of 260.00 USD and a min estimate of 190.00 USD. Watch PEN chart and read a more detailed Penumbra, Inc. stock forecast: see what analysts think of Penumbra, Inc. and suggest that you do with its stocks.
PEN reached its all-time high on Jun 30, 2023 with the price of 348.67 USD, and its all-time low was 35.32 USD and was reached on Oct 22, 2015. View more price dynamics on PEN chart.
See other stocks reaching their highest and lowest prices.
PEN stock is 1.97% volatile and has beta coefficient of 0.75. Track Penumbra, Inc. stock price on the chart and check out the list of the most volatile stocks — is Penumbra, Inc. there?
Today Penumbra, Inc. has the market capitalization of ‪9.18 B‬, it has increased by 2.44% over the last week.
Yes, you can track Penumbra, Inc. financials in yearly and quarterly reports right on TradingView.
Penumbra, Inc. is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
PEN earnings for the last quarter are 0.85 USD per share, whereas the estimation was 0.69 USD resulting in a 23.72% surprise. The estimated earnings for the next quarter are 0.88 USD per share. See more details about Penumbra, Inc. earnings.
Penumbra, Inc. revenue for the last quarter amounts to ‪301.04 M‬ USD, despite the estimated figure of ‪297.36 M‬ USD. In the next quarter, revenue is expected to reach ‪311.38 M‬ USD.
PEN net income for the last quarter is ‪29.53 M‬ USD, while the quarter before that showed ‪−60.20 M‬ USD of net income which accounts for 149.05% change. Track more Penumbra, Inc. financial stats to get the full picture.
No, PEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has ‪4.20 K‬ employees. See our rating of the largest employees — is Penumbra, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Penumbra, Inc. EBITDA is ‪108.18 M‬ USD, and current EBITDA margin is 11.56%. See more stats in Penumbra, Inc. financial statements.
Like other stocks, PEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Penumbra, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Penumbra, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Penumbra, Inc. stock shows the buy signal. See more of Penumbra, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.